Company intelligence / Profile preview
Shanghai ZuanZhi Biotechnology
Shanghai, Shanghai, Chinazuanzhibio.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Shanghai ZuanZhi Biotechnology is a clinical-stage biopharmaceutical company headquartered in Shanghai, China, specializing in the development of next-generation small molecule drugs. The company focuses on targeting historically undruggable oncogenic drivers, particularly within the RAS/MAPK signaling pathway. Its lead programs include potent and selective inhibitors of KRAS mutations, such as KRAS G12D and G12V, aimed at treating various solid tumors. ZuanZhi utilizes a proprietary structure-based drug design platform to accelerate the discovery of high-affinity candidates. Supported by leading venture capital firms, the company aims to provide transformative therapies for cancer patients globally.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Shanghai ZuanZhi Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai ZuanZhi Biotechnology.